Keji Pharmaceutical-B (02171.HK) rose by more than 11% during the day. As of press release, it rose 5.54% to HK$5.33, with a turnover of HK$9.66,200.
港股异动 | 科济药业-B(02171.HK)最高涨超11% CT053商业化落地 CT041研究成果将亮相2024 ASCO
Changes in Hong Kong stocks | Keji Pharmaceutical-B (02171.HK) rose by more than 11% CT053 commercialized and implemented CT041 research results to be unveiled in 2024 ASCO
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.